,20,25 Both classical (CD103−) and cDC1s (CD103+) with increased expression of the co-stimulatory molecules CD80 and CD40, essential for priming tumor-specific CTLs,18 were observed in increased numbers in OrfV-treated mice shortly thereafter the peak of the NK response. The gene discussed is CD40; the disease is neoplasm.